Jazz will still file anti-seizure med Epidiolex in Japan despite trial setback – Endpoints News
Jazz Pharmaceuticals’ oral cannabidiol drug Epidiolex has disappointed in a late-phase test in Japanese children with seizures, but the company …Read More
